Skip to main content
PCRX
NASDAQ Life Sciences

激进投资者要求更换Pacira CEO，援引知识产权诉讼风险

feedReported by Dow Jones Newswires
Sentiment info
Negative
Importance info
8
Price
$22.82
Mkt Cap
$923.979M
52W Low
$18.8
52W High
$27.64
Market data snapshot near publication time

summarizeSummary

DOMA Perpetual，一家激进投资者，公开要求更换Pacira BioSciences CEO Frank Lee，援引对公司战略方向的担忧，并敦促董事会避免进一步的知识产权诉讼风险。这一投资者对领导层和战略的公开挑战是重大发展，表明潜在的公司治理问题和战略分歧。虽然公司最近报告了返回GAAP净收入和在其Q4和全年2025结果中强劲的收入增长，但这种激进投资者的压力引入了关于未来领导层和战略关注点的不确定性。交易者将关注Pacira董事会或DOMA Perpetual的任何回应，这可能会升级为代理权争议。

在该公告发布时，PCRX的交易价格为$22.82，交易所为NASDAQ，所属行业为Life Sciences，市值约为$9.2亿。 52周交易区间为$18.80至$27.64。 这则新闻被评估为消极市场情绪，重要性评分为8/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed PCRX - Latest Insights

PCRX
Apr 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
EXPAREL Real-World Data Reveals Significant Opioid Reduction, Lower Medical Costs for Medicare Hip Patients
Sentiment: Positive
View Wiseek Article
PCRX
Apr 17, 2026, 4:15 PM EDT
Filing Type: PREC14A
Importance Score:
8
Pacira BioSciences Faces Contested Director Election and Seeks Approval for Significant Equity Plan Expansion Amidst Activist Pressure
Sentiment: Negative
View Wiseek Article
PCRX
Apr 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
New Data Shows Pacira's EXPAREL Lowers Healthcare Costs, Opioid Use in Outpatient Orthopedic Surgeries
Sentiment: Positive
View Wiseek Article
PCRX
Mar 12, 2026, 7:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Activist DOMA Perpetual Nominates Directors, Demands CEO Replacement and Company Sale
Sentiment: Negative
View Wiseek Article
PCRX
Mar 11, 2026, 5:02 PM EDT
Source: GlobeNewswire
Importance Score:
8
Pacira Counters Activist Investor, Highlights Strategic Progress and Shareholder Returns
Sentiment: Neutral
View Wiseek Article
PCRX
Mar 11, 2026, 3:25 PM EDT
Filing Type: DFAN14A
Importance Score:
9
Activist DOMA Perpetual Nominates Directors, Demands CEO Replacement & Formal Sale Process for Pacira BioSciences
Sentiment: Negative
View Wiseek Article
PCRX
Mar 11, 2026, 1:09 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Activist Investor Demands Pacira CEO Replacement, Cites IP Battle Risks
Sentiment: Negative
View Wiseek Article
PCRX
Feb 26, 2026, 4:16 PM EST
Filing Type: 10-K
Importance Score:
9
Pacira BioSciences Returns to Profitability in 2025 with Strong Revenue Growth and Strategic Progress
Sentiment: Positive
View Wiseek Article
PCRX
Feb 26, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
9
Pacira BioSciences Reports Strong 2025 Turnaround, Significant Share Repurchases, and Positive 2026 Outlook
Sentiment: Positive
View Wiseek Article
PCRX
Jan 28, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
8
Pacira BioSciences Appoints Dr. Samit Hirawat to Board Amidst Activist Investor Pressure
Sentiment: Positive
View Wiseek Article